We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$461B
AUM Growth
+$24.9B
Cap. Flow
-$12.1B
Cap. Flow %
-2.62%
Top 10 Hldgs %
40.03%
Holding
5,800
New
615
Increased
1,596
Reduced
2,751
Closed
340

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.34B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.65B
3
TSLA icon
Tesla
TSLA
+$1.45B
4
QQQ icon
Invesco QQQ Trust
QQQ
+$1.01B
5
AAPL icon
Apple
AAPL
+$833M

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Financials 7.27%
3 Consumer Discretionary 6.82%
4 Communication Services 5.06%
5 Healthcare 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBDY icon
3751
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
$1.09B
$499K ﹤0.01%
+19,019
New +$494K
IBDX icon
3752
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.7B
$499K ﹤0.01%
+19,470
New +$494K
ENTA icon
3753
Enanta Pharmaceuticals
ENTA
$366M
$498K ﹤0.01%
41,621
-6,267
-13% -$50.1K
GBFH
3754
GBank Financial Holdings
GBFH
$301M
$498K ﹤0.01%
12,681
-2,668
-17% -$105K
MNTK icon
3755
Montauk Renewables
MNTK
$243M
$498K ﹤0.01%
247,656
+90,897
+58% +$195K
RICK icon
3756
RCI Hospitality Holdings
RICK
$192M
$497K ﹤0.01%
16,274
+2,093
+15% +$75K
UIS icon
3757
Unisys
UIS
$209M
$496K ﹤0.01%
127,089
-20,566
-14% -$83.4K
CFLT
3758
CALL
DELISTED
Confluent
CFLT
$495K ﹤0.01%
+25,000
New +$523K
CFLT
3759
PUT
DELISTED
Confluent
CFLT
$495K ﹤0.01%
+25,000
New +$523K
NEWT icon
3760
NewtekOne
NEWT
$428M
$494K ﹤0.01%
43,180
+641
+2% +$7.59K
SNPS icon
3761
CALL
Synopsys
SNPS
$74.4B
$493K ﹤0.01%
1,000
-21,000
-95% -$11.9M
MCFT icon
3762
MasterCraft Boat Holdings
MCFT
$579M
$493K ﹤0.01%
22,956
-4,399
-16% -$91.9K
TITN icon
3763
Titan Machinery
TITN
$396M
$492K ﹤0.01%
29,361
-5,319
-15% -$104K
ACCO icon
3764
Acco Brands
ACCO
$390M
$491K ﹤0.01%
123,067
-23,015
-16% -$89.7K
WBTN
3765
WEBTOON Entertainment Inc
WBTN
$1.23B
$490K ﹤0.01%
25,269
-10,855
-30% -$145K
CRWD icon
3766
CALL
CrowdStrike
CRWD
$194B
$490K ﹤0.01%
+4,000
New +$455K
YB
3767
Yuanbao Inc
YB
$619M
$489K ﹤0.01%
24,883
-18,043
-42% -$458K
TBI
3768
Trueblue
TBI
$215M
$488K ﹤0.01%
79,637
-15,214
-16% -$96.2K
RCKT icon
3769
Rocket Pharmaceuticals
RCKT
$340M
$487K ﹤0.01%
149,393
-25,045
-14% -$78.9K
LBRX
3770
LB Pharmaceuticals
LBRX
$1.15B
$487K ﹤0.01%
+30,839
New +$489K
SWIM icon
3771
Latham Group
SWIM
$629M
$486K ﹤0.01%
63,805
-22,685
-26% -$167K
OM icon
3772
Outset Medical
OM
$84.7M
$485K ﹤0.01%
34,326
+2,026
+6% +$31.6K
SOXL icon
3773
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$16.7B
$484K ﹤0.01%
13,900
-3,801
-21% -$106K
HNST icon
3774
The Honest Company
HNST
$402M
$484K ﹤0.01%
131,454
-33,523
-20% -$142K
GLRE icon
3775
Greenlight Captial
GLRE
$552M
$482K ﹤0.01%
37,972
-5,504
-13% -$71.8K

Similar funds

Barclays's Q3 2025 Portfolio in Review

As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
  • Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
  • Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
  • Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
  • Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
  • Barclays opened 615 new positions and closed 340 in Q3 2025.
  • Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.